The METEX study: Methotrexate versus expectant management in women with ectopic pregnancy: A randomised controlled trial

BACKGROUND: Patients with ectopic pregnancy (EP) and low serum hCG concentrations and women with a pregnancy of unknown location (PUL) and plateauing serum hCG levels are commonly treated with systemic methotrexate (MTX). However, there is no evidence that treatment in these particular subgroups of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: van Mello, Norah M, Mol, Femke, Adriaanse, Albert H, Boss, Erik A, Dijkman, Antonius B, Doornbos, Johannes PR, Emanuel, Mark Hans, Friederich, Jaap, Leeuw-Harmsen, Loes van der, Lips, Jos P, van Santbrink, Evert JP, Verhoeve, Harold R, Visser, Harry, Ankum, Willem M, Veen, Fulco van der, Mol, Ben W, Hajenius, Petra J
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2008
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2453103/
https://ncbi.nlm.nih.gov/pubmed/18565217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6874-8-10
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars